Neurology
2 drugs are in development for Epilepsy.
- Companies
- 2
- Clinical trials
- 24
BioSniper AIPage evidence connected
Prepared research question
Which programs lead the Epilepsy pipeline—and what evidence could change the picture?
Run cited research
Traceable citations · Unknowns marked
Drug Pipeline by Phase
Phase 2(1)
| Drug | Company |
|---|---|
| rap-219 | Rapport Therapeutics, Inc. (RAPP) |
Preclinical(1)
| Drug | Company |
|---|---|
| aevi-004 | AEVI GENOMIC MEDICINE, INC. (GNMX) |
About this indication
Epilepsy context
Neurology·MeSH: Epilepsy (D004827)
Also known as: Epilepsies, Seizure Disorder, Seizure Disorders
Prevalence
700.0 / 100K
Incidence
48.0 / 100K/yr
Frequently asked questions
How many drugs are in development for Epilepsy?
BioSniper tracks 2 drugs in development for Epilepsy across 2 companies.
How many clinical trials target Epilepsy?
There are 24 clinical trials targeting Epilepsy tracked by BioSniper.
What is the prevalence of Epilepsy?
The estimated prevalence of Epilepsy is approximately 700.0 per 100,000 population.